Skip to content

The diagnostic value of late enhancement photon counting CT in myocardial scar with usage of different contrast media ILLUMINATE

The diagnostic value of late enhancement photon counting CT in myocardial scar with usage of different contrast media ILLUMINATE - ILLUMINATE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56221
Enrollment
20
Registered
2023-08-21
Start date
2024-06-12
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Myocardial infarction (chronic). The diagnosis myocardial infarction is based on clinical judgement and guideline definitions, such as complaints compatible with myocardial ischemia, ECG changes, cardiac troponin elevation. - Wall motion abnormalities in >=2 adjacent segments (on echocardiography) - Clinically referred for CMR (e.g. viability assessment) - Age 18-80 years of age

Exclusion criteria

Exclusion criteria: - Logistics: Inability to organize CT directly after CMR scan - Safety: pregnancy or breast-feeding - Safety: contraindications to CMR or CT * Metallic implant (vascular clip, neuro-stimulator, cochlear implant) * Pacemaker or implantable cardiac defibrillator (ICD) * Claustrophobia * Body weight >130 kg or BMI > 35 or body habitus that does not fit into the gantry * Contraindications to betablockers of nitrates - Safety: Renal failure (estimated Glomerular Filtration Rate (eGFR)

Design outcomes

Primary

MeasureTime frame
Detection of MI using spectral photon counting late enhancement (iodine/gadolinium) CT (extent, mass, percentage of left ventricle, transmurality)

Secondary

MeasureTime frame
• Correlation of infarct size measurement on CMR versus CT • Assessment of myocardial viability CMR versus CT • Assessment of kidney function after dual contrast infusion (eGFR/MDRD) • Detection of MI and CAD in a single CT scan

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026